Amsterdam Public Health
-
Effectiveness of the primary Bacillus Calmette-Guérin vaccine against the risk of Mycobacterium tuberculosis infection and tuberculosis disease: a meta-analysis of individual participant data
Pelzer, P. T., Stuck, L., Martinez, L., Richards, A. S., Acuña-Villaorduña, C., Aronson, N. E., Bonnet, M., Carvalho, A. C., Chan, P.-C., Huang, L.-M., Fang, C.-T., Churchyard, G., Corral-Londoño, H. D., Datta, M., Espinal, M. A., Fielding, K., Fiore-Gartland, A. J., Garcia-Basteiro, A., Hanekom, W. & Hatherill, M. & 22 others, , 19 Dec 2024, (E-pub ahead of print) In: The Lancet Microbe. 100961.Research output: Contribution to journal › Article* › Academic › peer-review
-
Schistosome and malaria exposure and urban–rural differences in vaccine responses in Uganda: a causal mediation analysis using data from three linked randomised controlled trials
POPVAC trial team, 1 Nov 2024, In: The Lancet Global Health. 12, 11, p. e1860-e1870Research output: Contribution to journal › Article* › Academic › peer-review
-
The effect of BCG revaccination on the response to unrelated vaccines in urban Ugandan adolescents (POPVAC C): an open-label, randomised controlled trial
POPVAC trial team, 1 Nov 2024, In: The Lancet Global Health. 12, 11, p. e1849-e1859Research output: Contribution to journal › Article* › Academic › peer-review
- All publications